Q3 Earnings Forecast for STOK Issued By HC Wainwright
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Equities research analysts at HC Wainwright issued their Q3 2025 earnings per share estimates for Stoke Therapeutics in a research note issued to investors on Wednesday, March 19th. HC Wainwright analyst A. Fein forecasts that the company will earn ($0.55) per share for the quarter. HC Wainwright […]
